Literature DB >> 24103085

Does estimated glomerular filtration rate have an effect on left ventricular function after ST-elevation myocardial infarction?

Osman Sonmez1, Mehmet A Vatankulu, Abdurrahman Tasal, Ahmet Bacaksiz, Selim Ayhan, Hüseyin U Yazici, Ekrem Karakaya, Ibrahim Ozdogru, Nazif Aygul, Kurtulus Ozdemir, Adnan Abaci.   

Abstract

OBJECTIVES: Little is known about whether estimated glomerular filtration rates (eGFR) affect left ventricular (LV) function and gain benefit with antiremodeling treatment in patients with ST-elevation myocardial infarction (STEMI). We investigated the effect of eGFR on LV function using tissue Doppler imaging (TDI) parameters. In addition, we sought to evaluate the antiremodeling effect of standard treatment at follow-up in patients with renal insufficiency (RI) after STEMI. METHODS AND
RESULTS: A retrospective analysis of 579 patients with STEMI was performed. Patients were divided into 3 groups according to eGFR (Group 1: eGFR > 90 mL/min per 1.73 m(2); Group 2: eGFR = 60-89 mL/min per 1.73 m(2); Group 3: eGFR < 60 mL/min per 1.73 m(2)). Conventional echocardiography and TDI were performed within 48-72 hours after STEMI and at 6-month follow-up. The mean left ventricular ejection fraction (LVEF) was significantly lower in Group 3 than in Group 1 (P = 0.021). The mean peak systolic velocity (Sm) was significantly lower in Group 3 than in Group 1 and Group 2 (P = 0.002 and 0.006, respectively). The estimated GFR had a linear association with Sm and LVEF (P = 0.001, r = 0.161; P = 0.005, r = 0.132, respectively). Multivariate analysis showed that an eGFR < 60 mL/min per 1.73 m(2) was an independent predictor of lower Sm and in-hospital mortality. In addition, an antiremodeling effect of standard treatment was seen in all groups at 6-month follow-up.
CONCLUSIONS: Estimated glomerular filtration rate of <60 mL/min per 1.73 m(2) was associated with lower LV function after STEMI, and may gain an antiremodeling effect with standard treatment at follow-up.
© 2013, Wiley Periodicals, Inc.

Entities:  

Keywords:  acute myocardial infarction; glomerular filtration rate; left ventricle remodeling; renal insufficiency; tissue Doppler

Mesh:

Year:  2013        PMID: 24103085     DOI: 10.1111/echo.12359

Source DB:  PubMed          Journal:  Echocardiography        ISSN: 0742-2822            Impact factor:   1.724


  5 in total

Review 1.  Influence of chronic kidney disease on cardiac structure and function.

Authors:  Kunihiro Matsushita; Shoshana H Ballew; Josef Coresh
Journal:  Curr Hypertens Rep       Date:  2015-09       Impact factor: 5.369

2.  The Impact of Admission Serum Creatinine Derived Estimated Glomerular Filtration Rate on Major Adverse Cardiac Events in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Mahmut Uluganyan; Gurkan Karaca; Turker Kemal Ulutas; Ahmet Ekmekci; Eyup Tusun; Ahmet Murat; Bayram Koroglu; Huseyin Uyarel; Nijad Bakhshaliyev; Mehmet Eren
Journal:  J Clin Med Res       Date:  2016-02-27

3.  Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction.

Authors:  Mohammad A Almesned; Femke M Prins; Erik Lipšic; Margery A Connelly; Erwin Garcia; Robin P F Dullaart; Hilde E Groot; Pim van der Harst
Journal:  J Clin Med       Date:  2021-12-01       Impact factor: 4.241

4.  The Impact of Admission Serum Creatinine on Major Adverse Clinical Events in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention.

Authors:  Poornima Vinod; Taylor Kann; Shyam Polaconda; Alibel Bello; Mohamed Khayata; Fernando Munoz; Vinod Krishnappa; Rupesh Raina
Journal:  Cardiol Res       Date:  2018-04-25

5.  The dose-response association between estimated glomerular filtration rate and prognosis of patients with ST-segment elevation myocardial infarction from rural areas of China's Liaoning province.

Authors:  Guangxiao Li; Guoxian Qi; Bo Zhang; Bo Zhou; Bing Ma; Daming Jiang; Qiao He; Cong Ai; Huixu Dai; Ying Li; Jingpu Shi
Journal:  Medicine (Baltimore)       Date:  2017-12       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.